TP53 and breast cancer: Similar to TN breast cancer and HGS-OvCa, almost all lung squamous cell carcinoma (lung SqCC) exhibited frequent somatic mutations of TP53 (81%), while both EGFR and KRAS mutations were almost absent [97].